Xcel Pharmaceuticals Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 125

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $280M

Xcel Pharmaceuticals General Information

Description

Manufacturer of prescription products for the treatment of central nervous system disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6363 Greenwich Drive
  • Suite 100
  • San Diego, CA 92122
  • United States
+1 (858)
Primary Industry
Pharmaceuticals
Corporate Office
  • 6363 Greenwich Drive
  • Suite 100
  • San Diego, CA 92122
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xcel Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Mar-2005 $280M Completed Profitable
3. Early Stage VC 01-Apr-2003 Completed Generating Revenue
2. Early Stage VC 01-Jun-2002 $22.5M $92.5M Completed Profitable
1. Early Stage VC 01-Mar-2001 $70M $70M Completed Product Development
To view Xcel Pharmaceuticals’s complete valuation and funding history, request access »

Xcel Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xcel Pharmaceuticals Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Domain Associates Venture Capital Minority
Ferrer Freeman & Company PE/Buyout
Greenspring Associates Venture Capital Minority
New Enterprise Associates Venture Capital Minority
To view Xcel Pharmaceuticals’s complete investors history, request access »

Xcel Pharmaceuticals Investments (1)

Xcel Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Pozen (MT-300 U.S. Marketing Rights) for . The deal was made on 04-Sep-2003.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pozen (MT-300 U.S. Marketing Rights) 04-Sep-2003 Corporate Asset Purchase Buildings and Property
To view Xcel Pharmaceuticals’s complete investments history, request access »

Xcel Pharmaceuticals FAQs

  • When was Xcel Pharmaceuticals founded?

    Xcel Pharmaceuticals was founded in 2001.

  • Where is Xcel Pharmaceuticals headquartered?

    Xcel Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Xcel Pharmaceuticals?

    Xcel Pharmaceuticals has 125 total employees.

  • What industry is Xcel Pharmaceuticals in?

    Xcel Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Xcel Pharmaceuticals a private or public company?

    Xcel Pharmaceuticals is a Private company.

  • What is the current valuation of Xcel Pharmaceuticals?

    The current valuation of Xcel Pharmaceuticals is .

  • What is Xcel Pharmaceuticals’s current revenue?

    The current revenue for Xcel Pharmaceuticals is .

  • How much funding has Xcel Pharmaceuticals raised over time?

    Xcel Pharmaceuticals has raised $180M.

  • Who are Xcel Pharmaceuticals’s investors?

    Domain Associates, Ferrer Freeman & Company, Greenspring Associates, and New Enterprise Associates have invested in Xcel Pharmaceuticals.

  • When was Xcel Pharmaceuticals acquired?

    Xcel Pharmaceuticals was acquired on 01-Mar-2005.

  • Who acquired Xcel Pharmaceuticals?

    Xcel Pharmaceuticals was acquired by Bausch Health Companies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process